Fear in US as drug shortages mount

September 4, 2011 by Jean-Louis Santini

Shortages of vital drugs, particularly cancer-fighting medication, have raised concerns in the United States, where regulators often have to race to try to find replacements.

A recent report by the (FDA) found that the number of important treatments that are difficult or impossible to find nearly tripled from 61 to 178 between 2005 and 2010.

Most of the rare medications are for hospital use, including sterile injections, intravenous treatments, and antibiotics. The products include both name-brand and generic drugs.

"FDA hears from patients and also from and organizations about the terrible impact the shortages have had," spokeswoman Shelly Burgess said.

"We continue to do all we can under our current authority to address shortages when they occur."

The FDA's efforts are hindered, however, because it cannot force private to produce certain drugs or even require them to notify the agency when they plan to discontinue one, Burgess said.

In 2010 it was able to avert 38 shortages, mainly by persuading other manufacturers to produce the drugs or helping to resolve production issues.

But a survey of 820 hospitals carried out in June by the American Hospital Association found that almost all had run out of an important drug over the past six months.

Eighty-percent said they had to delay patient treatments because of scarcity, and 70 percent said they administered less effective treatments.

"We really need to take a very careful look at what is going on. I have never seen anything like this and I have been a for over 40 years," says Mike Cohen, a pharmacist at the non-profit Safe .

The group recently surveyed 1,800 and found that a third of doctors and a fifth of pharmacists were aware of adverse reactions in their patients -- including deaths -- because of .

Cynthia Reilly of the American Society of Health System Pharmacists says the "dramatic increase" in shortages is in part due to "quality issues."

"In a lot of instances the manufacturer is either having problems with the production lines or perhaps they found particular products in vials so they have to do a recall," she said.

Reilly fears the shortages will worsen as the pharmaceutical industry continues to consolidate, and as more companies stop producing because they are less profitable.

"A few years ago five companies were making a similar product. Now there is only one or two... There are not a lot of companies to fill the gap," she said.

She and other advocates believe new legislation to allow the FDA to force companies to alert it six months in advance of closing a production line would be helpful, as it would give the agency more time to find a substitute.

Two bills with broad support are currently under discussion in Congress.

Another problem is the so-called "gray market," whereby distributors scoop up rare drugs and then charge hospitals exorbitant rates for them. Some drugs can fetch up to 1,000 times the normal price.

"We tell our members to contact their state attorney general. Unfortunately there is opportunity for unscrupulous behavior," Reilly said.

Explore further: US drug supplies run short, endangering patients

Related Stories

US drug supplies run short, endangering patients

August 19, 2011
Monika McBride has acute myeloid leukemia, a life-threatening blood cancer that requires six months of intensive chemotherapy. Three days before her third treatment, however, a nurse called to cancel her appointment: Her ...

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...


Adjust slider to filter visible comments by rank

Display comments: newest first

4.3 / 5 (4) Sep 04, 2011
Bush accused of pressuring countries to stop producing generic drugs


Bush Signed Law Blocking Generic Drug

Campaign: Texas was one of just three states to make it harder for doctors to prescribe cheaper blood-thinner.


5 / 5 (1) Sep 04, 2011
5 / 5 (2) Sep 06, 2011
A definite failure of the Free Market model.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.